CKS2 and lung adenocarcinoma: In a study on lung adenocarcinoma, it was found that CKS2 expression affected the sensitivity of lung adenocarcinoma cells to carboplatin and paclitaxel, and the higher CKS2 expression, the higher the sensitivity of paclitaxel.